Evaluating Qigong as a Clinical Intervention for Cancer Survivors' Fatigue

NCT02845492 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-08-01

No results posted yet for this study

Summary

This study compares Qigong movement-based meditation exercise with a healthy living exercise-wellness course. There are two primary goals of this research:

1. Evaluate and compare physiological mechanisms underlying the two wellness-exercise interventions with the specific goal of understanding the physiology of Qigong.

Using a simple noninvasive EEG setup, the study will test some of the same brain mechanisms that have been found in mindfulness meditation.

The study will also investigate Qigong's effects on stress and heart signals and on inflammation in the immune system. A key hypothesis is that Qigong will show distinctive, stronger effects on brain and heart measures. A related hypothesis is that Qigong will show stronger effects on blood markers of inflammation.
2. Compare effect sizes of the two interventions in decreasing fatigue in order to plan for a larger clinical trial.

Conditions

Interventions

OTHER

Qigong

Qigong is a mind-body exercise based around gentle exercise and the cultivation of a meditative focus on bodily sensations

OTHER

Complete Health Improvement Program (CHIP)

The CHIP program is a validated weekly wellness and exercise program designed to promote health and wellbeing.

Sponsors & Collaborators

  • Brown University

    collaborator OTHER
  • The Miriam Hospital

    lead OTHER

Principal Investigators

  • Catherine Kerr, PhD · Women's Medicine Collaborative, Miriam Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-04-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02845492 on ClinicalTrials.gov